(Q33838421)

29 July 2017

1 reference

title

Stress, corticotropin-releasing factor, and drug addiction (English)

1 reference

29 July 2017

0 references

Koob GF

1

1 reference

PubMed ID

10676433

29 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Annals of the New York Academy of Sciences

29 July 2017

1 reference

29 July 2017

897

1 reference

29 July 2017

27-45

1 reference

The Stress Response: A New Perspective

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Distribution of urocortin-like immunoreactivity in the central nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin releasing factor produces behavioural activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

The effects of ICV-CRH on novelty-induced behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

CRF antagonist partially reverses CRF- and stress-induced effects on feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Role of corticotropin-releasing factor (CRF) as a food intake regulator in goldfish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Both conditioned taste preference and aversion induced by corticotropin-releasing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Molecular and cellular aspects of nicotine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Specificity in the projection patterns of accumbal core and shell in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Transition from moderate to excessive drug intake: change in hedonic set point.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

Neuroscience of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07876.X

10.1111/J.1749-6632.1999.TB07876.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10676433